Skip to content

Optical Coherence Tomography Evaluation of Retinoschisis and Retinal Detachment

Use of Spectral Domain Optical Coherence Tomography to Differentiate and Follow-up Senile Retinoschisis and Retinal Detachment

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02682797
Enrollment
44
Registered
2016-02-15
Start date
2013-09-30
Completion date
2016-07-31
Last updated
2016-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinoschisis

Brief summary

Retinoschisis is usually a rare self-limited disease and seldom shows progression. There a splitting of the neurosensory retina occurs usually in the inferior temporal. Patients usually have good visual acuity and are asymptomatic. Combination of an inner and outer layer hole is considered high risk factor for development of a schisis detachment. The most important differential diagnosis is an retinal detachment, since if misdiagnosed unnecessary treatment is provided. In clinical examination, both can appear very thin and transparent. Therefore exact diagnosis of retinoschisis and retinal detachment has to be assessed and regular follow-up controls have to be conducted for sufficient recognition of progression.

Interventions

None listed

Sponsors

Medical University of Vienna
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or female, at least 18 years of age. * Ophthalmoscopic evidence of RS or RD * Written informed consent has been obtained.

Exclusion criteria

* Progression of retinal detachment or retinoschisis requiring surgical treatment * Contraindication to pupil dilation, known allergy.

Design outcomes

Primary

MeasureTime frame
Morphological findings in retinoschisis or retinal detachment in optical coherence tomography scans during follow-upBaseline
Change or progression of disease measured in optical coherence tomography2 years

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026